Telo Genomics Corp (TSE:TELO)
TSXV:TELO

Telo Genomics Corp (TELO) Income Statement

18 Followers

Telo Genomics Corp Income Statement

Last quarter (Q2 2024), Telo Genomics Corp's total revenue was C$―, a decrease of ― from the same quarter last year. In Q2, Telo Genomics Corp's net income was C$-835.14K. See Telo Genomics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Revenue
----C$ 0.00C$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 3.07MC$ 2.82MC$ 2.11MC$ 1.26MC$ 1.31MC$ 1.05M
Operating Income
C$ -3.07MC$ -2.82MC$ -2.11MC$ -1.26MC$ -1.31MC$ -1.05M
Net Non Operating Interest Income Expense
----C$ -26.54KC$ -20.67K
Other Income Expense
---C$ 187.23KC$ 95.70K-
Pretax Income
C$ -3.07MC$ -2.82MC$ -2.11MC$ -1.07MC$ -1.24MC$ -1.07M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -3.07MC$ -2.82MC$ -2.11MC$ -1.07MC$ -1.24MC$ -1.07M
Basic EPS
C$ -0.04C$ -0.05C$ -0.04C$ -0.02C$ -0.04C$ -0.08
Diluted EPS
C$ -0.04C$ -0.05C$ -0.04C$ -0.02C$ -0.04C$ -0.08
Basic Average Shares
C$ 264.38MC$ 60.15MC$ 58.66MC$ 46.89MC$ 29.93MC$ 13.23M
Diluted Average Shares
C$ 264.38MC$ 60.15MC$ 58.66MC$ 46.89MC$ 29.93MC$ 13.23M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 3.07MC$ 2.82MC$ 2.11MC$ -1.26MC$ 1.31MC$ 1.05M
Net Income From Continuing And Discontinued Operation
C$ -3.07MC$ -2.82MC$ -2.11MC$ -1.07MC$ -1.24MC$ -1.07M
Normalized Income
C$ -2.26MC$ -2.07MC$ -1.55MC$ -973.66KC$ -1.24MC$ -1.07M
Interest Expense
----C$ 26.54KC$ 20.67K
EBIT
C$ -3.07MC$ -2.82MC$ -2.11MC$ -1.07MC$ -1.22MC$ -1.05M
EBITDA
C$ -3.03MC$ -2.79MC$ -2.05MC$ -1.01MC$ -1.15MC$ -970.61K
Currency in CAD

Telo Genomics Corp Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis